Authors:
Vahteristo, P
Syrjakoski, K
Eerola, H
Kainu, T
Holli, K
Blomqvist, C
Kallioniemi, OP
Nevanlinna, H
Citation: P. Vahteristo et al., Re: Population-based study of BRCA1 and BRCA2 mutations in 1035 unselectedFinnish breast cancer patients - Response, J NAT CANC, 93(2), 2001, pp. 153-154
Authors:
Barkardottir, RB
Sarantaus, L
Arason, A
Vehmanen, P
Bendahl, PO
Kainu, T
Syrjakoski, K
Krahe, R
Huusko, P
Pyrhonen, S
Holli, K
Kallioniemi, OP
Egilsson, V
Kere, J
Nevanlinna, H
Citation: Rb. Barkardottir et al., Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families, EUR J HUM G, 9(10), 2001, pp. 773-779
Authors:
Jukkola, A
Bloigu, R
Soini, Y
Savolainen, ER
Holli, K
Blanco, G
Citation: A. Jukkola et al., c-erbB-2 Positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease, EUR J CANC, 37(3), 2001, pp. 347-354
Authors:
Paakkonen, K
Sauramo, S
Sarantaus, L
Vahteristo, P
Hartikainen, A
Vehmanen, P
Ignatius, J
Ollikainen, V
Kaariainen, H
Vauramo, E
Nevanlinna, H
Krahe, R
Holli, K
Kere, J
Citation: K. Paakkonen et al., Involvement of BRCA1 and BRCA2 in breast cancer in a Western Finnish sub-population, GENET EPID, 20(2), 2001, pp. 239-246
Authors:
Lundin, J
Lundin, M
Holli, K
Kataja, V
Elomaa, L
Pylkkanen, L
Turpeenniemi-Hujanen, T
Joensuu, H
Citation: J. Lundin et al., Omission of histologic grading from clinical decision making may result inoveruse of adjuvant therapies in breast cancer: Results from a nationwide study, J CL ONCOL, 19(1), 2001, pp. 28-36
Authors:
Jukkola, A
Bloigu, R
Holli, K
Joensuu, H
Valavaara, R
Risteli, J
Blanco, G
Citation: A. Jukkola et al., Postoperative PINP in serum reflects metastatic potential and poor survival in node-positive breast cancer, ANTICANC R, 21(4B), 2001, pp. 2873-2876
Authors:
Holli, K
Saaristo, R
Isola, J
Joensuu, H
Hakama, M
Citation: K. Holli et al., Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study, BR J CANC, 84(2), 2001, pp. 164-169
Authors:
Syrjakoski, K
Vahteristo, P
Eerola, H
Tamminen, A
Kivinummi, K
Sarantaus, L
Holli, K
Blomqvist, C
Kallioniemi, OP
Kainu, T
Nevanlinna, H
Citation: K. Syrjakoski et al., Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients, J NAT CANC, 92(18), 2000, pp. 1529-1531
Authors:
Sarantaus, L
Huusko, P
Eerola, H
Launonen, V
Vehmanen, P
Rapakko, K
Gillanders, E
Syrjakoski, K
Kainu, T
Vahteristo, P
Krahe, R
Paakkonen, K
Hartikainen, J
Blomqvist, C
Lopponen, T
Holli, K
Ryynanen, M
Butzow, R
Borg, A
Arver, BW
Holmberg, E
Mannermaa, A
Kere, J
Kallioniemi, OP
Winqvist, R
Nevanlinna, H
Citation: L. Sarantaus et al., Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland, EUR J HUM G, 8(10), 2000, pp. 757-763
Authors:
Holli, K
Valavaara, R
Blanco, G
Kataja, V
Hietanen, P
Flander, M
Pukkala, E
Joensuu, H
Citation: K. Holli et al., Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer, J CL ONCOL, 18(20), 2000, pp. 3487-3494
Authors:
Joensuu, H
Holli, K
Oksanen, H
Valavaara, R
Citation: H. Joensuu et al., Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer, BREAST CANC, 63(3), 2000, pp. 225-234
Authors:
Kainu, T
Juo, SHH
Desper, R
Schaffer, AA
Gillanders, E
Rozenblum, E
Freas-Lutz, D
Weaver, D
Stephan, D
Bailey-Wilson, J
Kallioniemi, OP
Tirkkonen, M
Syrjakoski, K
Kuukasjarvi, T
Koivisto, P
Karhu, R
Holli, K
Arason, A
Johannesdottir, G
Bergthorsson, JT
Johannsdottir, H
Egilsson, V
Barkardottir, RB
Johannsson, O
Haraldsson, K
Sandberg, T
Holmberg, E
Gronberg, H
Olsson, H
Borg, A
Vehmanen, P
Eerola, H
Heikkila, P
Pyrhonen, S
Nevanlinna, H
Citation: T. Kainu et al., Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus, P NAS US, 97(17), 2000, pp. 9603-9608
Authors:
Jarvinen, TAH
Pelto-Huikko, M
Holli, K
Isola, J
Citation: Tah. Jarvinen et al., Estrogen receptor beta is coexpressed with ER alpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer, AM J PATH, 156(1), 2000, pp. 29-35
Citation: K. Holli et al., Changes in importance of items in the social and personal life of breast cancer patients over time, BREAST, 8(3), 1999, pp. 155-156
Authors:
Saarenmaa, I
Salminen, T
Geiger, U
Holli, K
Isola, J
Karkkainen, A
Pakkanen, J
Piironen, A
Salo, A
Hakama, M
Citation: I. Saarenmaa et al., The visibility of cancer on earlier mammograms in a population-based screening programme, EUR J CANC, 35(7), 1999, pp. 1118-1122
Authors:
Holli, K
Laippala, P
Ojala, A
Pitkanen, M
Citation: K. Holli et al., Quality control in health care: An experiment in radiotherapy planning forbreast cancer patients after mastectomy, INT J RAD O, 44(4), 1999, pp. 827-833
Authors:
Joensuu, H
Holli, K
Heikkinen, M
Suonio, E
Aro, AR
Hietanen, P
Huovinen, R
Citation: H. Joensuu et al., Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: A prospective randomized trial, J CL ONCOL, 16(12), 1998, pp. 3720-3730